| Clinical data | |
|---|---|
| Other names | 6α,9α-Difluoro-11β,17α-dihydroxy-16α-methyl-21-thia-21-fluoromethylpregna-1,4-dien-3,20-dione; S-(Fluoromethyl)-6α,9α-difluoro-11β,17α-dihydroxy-16α-methyl-3-oxoandrosta-1,4-diene-17β-carbothioate |
| Routes of administration | Intranasal, inhalation, topical |
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Bioavailability | 0.51% (Intranasal) |
| Protein binding | 91.0% |
| Metabolism | Intranasal Liver (CYP3A4-mediated) |
| Elimination half-life | 10 hours |
| Excretion | Kidney |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C22H27F3O4S |
| Molar mass | 444.51 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Fluticasone is a manufactured glucocorticoid used to treat nasal congestion. Both the esters, fluticasone propionate (sold as Flovent) and fluticasone furoate, are also used as topical anti-inflammatories and inhaled corticosteroids, and are used much more commonly in comparison.[compared to?]
Fluticasone is on the World Health Organization's List of Essential Medicines. In 2024, it was the 23rd most commonly prescribed medication in the United States, with more than 22 million prescriptions.
| Glucocorticoids | |
|---|---|
| Antiglucocorticoids |
|
| Synthesis modifiers | |
| |
Decongestants and other nasal preparations (R01) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Topical |
| ||||||||||
| Systemic use: Sympathomimetics | |||||||||||
| |||||||||||
| GRTooltip Glucocorticoid receptor |
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Subsidiaries |
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Predecessors, acquisitions | |||||||||
| Products |
| ||||||||
| People |
| ||||||||
| Litigation | |||||||||
| Other | |||||||||